Skip navigation

FDA has safety concerns with Merck insomnia drug

Federal health regulators say an experimental insomnia drug from Merck can help patients fall asleep, but it also carries worrisome side effects, including daytime drowsiness and suicidal thinking. Full story

FDA approves radiation-based prostate cancer drug

The Food and Drug Administration has approved a new injectable drug that uses radiation to treat advanced prostate cancer that has spread to the bones. Full story

FDA recommends lower Ambien dosage

   Those who take products containing zolpidem, best known by the drug’s brand name Ambien, are now being advised to take less of the medication. NBC’s Brian Williams reports.

Invacare rises as FDA OKs audit of Ohio plant

Shares of Invacare Corp. advanced Tuesday after the company said it is making progress in a government review of an Ohio facility. The FDA had limited production at the plant because of manufacturing problems. Full story

FDA approves labels with lower doses for zolpidem sleep drugs

(Reuters) - The Food and Drug Administration approved label changes incorporating lower dosages for sleep medications containing zolpidem, a drug that can continue to affect patients' mental alertness even a day after its use. Full story

FDA accepts Seattle Genetics Adcetris application

Drug developer Seattle Genetics Inc. said Tuesday the Food and Drug Administration has accepted its application to market the lymphatic cancer treatment Adcetris for some additional uses. Full story

Sponsored Links

Articles

House panel questions resignation of top FDA official

Acadia rises as analyst considers sale possibility

FDA allows generic forms of Endo Health's Opana ER painkiller

Judge denies FDA bid to stay 'morning-after' pill ruling

FDA approves once-a-day inhaler from Glaxo

State pharmacy boards back more FDA oversight

Wrigley takes new caffeinated gum off market

10 Things to Know for Thursday

FDA inspection triggers recall by Florida pharmacy

Judge criticizes FDA move on Plan B, agency warns of precedent

Video

  FDA reviewing chemical found in liquid soap

The FDA is reviewing whether triclosan, an antibacterial chemical contained in liquid soap and body wash, may be ineffective or even harmful to humans. Recent studies on animals have shown an increased risk of infertility, early puberty and other hormonal issues.

  The White House’s backup plan for Plan B

President Obama is defending his administration’s decision to appeal a ruling for the Plan B pill. Alex Wagner and the NOW panel discuss.

  Obama admin will continue to push Plan B age restrictions in appeal

Chris Hayes looks at the Obama administration's decision to appeal an April court ruling that ordered that Plan B be made available to women of all ages.

  CPSI: ‘We really should be concerned’ about caffeinated foods

After years of concern about the effects of energy drinks on kids, the FDA is now focusing on caffeine in foods ranging from chips to chewing gum. Michael Jacobson, the executive director of the Center for Science in the Public Interest, warns that caffeinated snacks could cause health problems for

  Paul Ryan reverses stance on gay adoption

MSNBC’s Thomas Roberts talks to a political power panel about Rep. Paul Ryan change in opinion on gay adoption, the FDA’s groundbreaking ruling on Plan B and the situation in Syria.

advertisement | ad info

Related Photos

Plan B One-Step
Plan B One-Step

This undated image made available by Teva Women's Health shows the packaging for their Plan B One-Step tablet, one of the brands known as the "morning-after pill." The Plan B morning-after pill is moving over-the-counter, a decision announced by the Food and Drug Administration just days before a c

Plan B
Plan B

CHICAGO, IL - APRIL 05: This photo illustration shows a package of Plan B contraceptive on April 5, 2013 in Chicago, Illinois. A federal judge in New York City has ordered the Food and Drug Administration to make Plan B contraceptive, also known as the morning after pill, available to younger teens

File photo of Staff Scientist Ji Guo inspecting dyes in a laboratory at the U.S. Food and Drug Administration (FDA) in Silver Spring
File photo of Staff Scientist Ji Guo inspecting dyes in a laboratory at the U.S. Food and Drug Administration (FDA) in Silver Spring

Staff Scientist Ji Guo inspects test tubes containing dyes in a laboratory at the U.S. Food and Drug Administration in Silver Spring, Maryland in this file photo from August 14, 2012. Picture taken August 14, 2012. The Food and Drug Administration announced a reduction of $133 million in non-user

  Inspections in Los Angeles

Inside look at border inspection and testing facilities in California.